For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
Plus Therapeutics Inc (NASDAQ: PSTV) closed the day trading at $0.49 down -0.12% from the previous closing price of $0.49. In other words, the price has decreased by -$0.12 from its previous closing price. On the day, 4.34 million shares were traded. PSTV stock price reached its highest trading level at $0.5222 during the session, while it also had its lowest trading level at $0.481.
Ratios:
For a better understanding of PSTV, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.20 and its Current Ratio is at 1.20. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, D. Boral Capital on March 17, 2025, initiated with a Buy rating and assigned the stock a target price of $9.
On January 25, 2021, Ladenburg Thalmann started tracking the stock assigning a Buy rating and target price of $8. On October 16, 2020, Maxim Group started tracking the stock assigning a Buy rating and target price of $6.Maxim Group initiated its Buy rating on October 16, 2020, with a $6 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 22 ’25 when Lenk Robert P bought 110,000 shares for $0.49 per share. The transaction valued at 53,779 led to the insider holds 139,327 shares of the business.
Petersen Greg bought 36,666 shares of PSTV for $20,276 on May 15 ’25. On Sep 13 ’24, another insider, Hawkins Richard J, who serves as the Director of the company, bought 4,000 shares for $1.50 each. As a result, the insider paid 5,996 and bolstered with 15,188 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PSTV now has a Market Capitalization of 48153208 and an Enterprise Value of 41363780. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.05 while its Price-to-Book (P/B) ratio in mrq is 14.74. Its current Enterprise Value per Revenue stands at 7.78 whereas that against EBITDA is -3.404.
Stock Price History:
The Beta on a monthly basis for PSTV is 0.67, which has changed by -0.66438353 over the last 52 weeks, in comparison to a change of 0.14460516 over the same period for the S&P500. Over the past 52 weeks, PSTV has reached a high of $2.31, while it has fallen to a 52-week low of $0.16. The 50-Day Moving Average of the stock is 8.63%, while the 200-Day Moving Average is calculated to be -41.83%.
Shares Statistics:
Over the past 3-months, PSTV traded about 31.90M shares per day on average, while over the past 10 days, PSTV traded about 9469920 shares per day. A total of 99.26M shares are outstanding, with a floating share count of 99.02M. Insiders hold about 0.25% of the company’s shares, while institutions hold 3.19% stake in the company. Shares short for PSTV as of 1753920000 were 1863220 with a Short Ratio of 0.06, compared to 1751241600 on 5739993. Therefore, it implies a Short% of Shares Outstanding of 1863220 and a Short% of Float of 3.09.
Earnings Estimates
Current recommendations for the stock of the company come from 1.0 analysts. The consensus estimate for the next quarter is -$0.03, with high estimates of -$0.03 and low estimates of -$0.03.
Analysts are recommending an EPS of between -$0.33 and -$0.33 for the fiscal current year, implying an average EPS of -$0.33. EPS for the following year is -$0.38, with 2.0 analysts recommending between -$0.14 and -$0.61.
Revenue Estimates
4 analysts predict $1.5M in revenue for the current quarter. It ranges from a high estimate of $3.32M to a low estimate of $189k. As of the current estimate, Plus Therapeutics Inc’s year-ago sales were $1.46MFor the next quarter, 4 analysts are estimating revenue of $1.62M. There is a high estimate of $3.63M for the next quarter, whereas the lowest estimate is $700k.
A total of 4 analysts have provided revenue estimates for PSTV’s current fiscal year. The highest revenue estimate was $9.4M, while the lowest revenue estimate was $2.01M, resulting in an average revenue estimate of $5.16M. In the same quarter a year ago, actual revenue was $5.82MBased on 4 analysts’ estimates, the company’s revenue will be $6.34M in the next fiscal year. The high estimate is $12.11M and the low estimate is $4M.
